Growth startup

Who invested in Nevakar

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 31 Oct 2026

$50Mraised across 1 round since 2019, from 1 source

Latest round
Growth, $50MJun 2019
Investors
0
See who backed them

The rounds

  1. Jun 2019
    Growth$50M

    No investor was named in the report.

    Source recorded

Founders and team

From the SEC filings it signed: 3 on the team.

  • Navneet PuriExecutive Officer, Directori
  • Raul TrilloExecutive Officer, Directori
  • Sri RamanathanExecutive Officeri

On the board, as filediAlex SissonGeorge ZorichRam PottiRon Wooten

Also claim to have backed them

This firm lists Nevakar as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

NovaQuestPrivate equityPer its own site

Quick answers about Nevakar

How much has Nevakar raised?

Nevakar has raised $50M across 1 round since 2019.

When did Nevakar last raise?

Nevakar's most recent round was a Growth of $50M in Jun 2019.

What was Nevakar's biggest round?

Its most recent round, $50M in Jun 2019, is also its largest on record.

What stage is Nevakar at?

Nevakar's latest named round is a Growth, in Jun 2019.

Companies like Nevakar

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.